Newsletter

Charlie Youlden

Charlie is an Associate Equity Research Analyst covering ASX small caps across technology, mining and industrials.

His investing journey began in 2020 with large-cap US technology stocks, before he went on to complete a Commerce degree in Finance and Marketing at UTS, the Wall Street Prep Financial Modelling course, and Columbia Business School’s Value Investing course.

Charlie’s goal is to make investing clear, digestible and genuinely useful for everyday retail investors, helping them make better decisions with more confidence.

776 articles published

Uncategorized

Why Long-Term Investing Still Beats Fast Money Dreams

Fast money has a loud voice. It appears in viral posts, lucky screenshots, sudden market stories, and friendly advice that sounds almost too easy. The promise is simple: move quickly, take a bold risk, and watch money grow overnight. Long-term investing speaks differently. It is quieter, slower, and less glamorous, but history has shown that…

ByCharlie Youlden14 hours ago0Comments

AI Stocks International Stocks Tech Stocks

SpaceX (NSDQ:SPCX) prices US$135 IPO as orbital AI becomes the story

SpaceX (NSDQ:SPCX) prices its IPO at US$135 per share, with the orbital AI compute pitch quietly anchoring the valuation case.

ByCharlie Youlden1 day ago0Comments

Defence Stocks Small Caps Stocks Tech Stocks

Electro Optic Systems (ASX:EOS) SPP closes 4x oversubscribed at A$95m

Electro Optic Systems (ASX:EOS) closes its SPP with A$95m in applications from 4,909 holders, upsized to A$40m at A$8 per share.

ByCharlie Youlden1 day ago0Comments

Healthcare Stocks Small Caps Stocks

OncoSil Medical (ASX:OSL) flags a catalyst-heavy back half of 2026

OncoSil Medical (ASX:OSL) launched a new Investor Hub and flagged a catalyst-rich second half of 2026 spanning FDA, clinical and manufacturing milestones.

ByCharlie Youlden1 day ago0Comments

Bank Stocks Financials Large Caps

ANZ (ASX:ANZ) hands its NZ bank to a risk officer

ANZ Group Holdings (ASX:ANZ) names CRO Ben Kelleher to replace retiring NZ CEO Antonia Watson, signalling a risk-first chapter for the NZ bank.

ByCharlie Youlden1 day ago0Comments

Gold Stocks Resources Small Caps Stocks

Great Northern Minerals (ASX:GNM) drops 480,000oz maiden resource at Iron Butte

Great Northern Minerals (ASX:GNM) delivers a maiden 480,000oz gold and 11.5Moz silver resource at Iron Butte in Nevada’s Battle Mountain district.

ByCharlie Youlden1 day ago0Comments

Biotech Stocks Healthcare Stocks Small Caps Stocks

Microba (ASX:MAP) raises A$5m and Sonic Healthcare keeps writing cheques

Microba Life Sciences (ASX:MAP) raises A$5m at a 20.6% discount with Sonic Healthcare backing the round, targeting CY2027 cashflow break-even.

ByCharlie Youlden1 day ago0Comments

Healthcare Stocks Life Sciences Small Caps Stocks

Vitrafy (ASX:VFY) raises A$30m at a 31.6% discount to chase 2027

Vitrafy Life Sciences (ASX:VFY) raises A$30m at a 31.6% discount to scale US operations ahead of the 2027 blood industry cryopreservation deadline.

ByCharlie Youlden1 day ago0Comments

Agriculture Stocks Penny Stocks Small Caps Stocks

BPH Global (ASX:BP8) clocks A$3.4m sales and quietly buries the kefir story

BPH Global (ASX:BP8) reframes as a seven-vertical seaweed platform with A$3.4m in trading sales. We look at whether the numbers support the pitch.

ByCharlie Youlden1 day ago0Comments

AI Stocks

Oracle (NYSE:ORCL) Shares Fall 7% Despite the Beat as Red Flags Build

Beats Expectations, But the 7% Sell-Off Exposes Bigger Risks Following our Q3 FY26 report, which flagged the inflection in cloud infrastructure demand, Oracle’s US$553 billion RPO backlog and accelerating capex build-out, Q4 demonstrates an even stronger growth story but with some cautious red flags. Remaining performance obligations (backlog contracts) reached US$638 billion, while Infrastructure-as-a-Service revenue…

ByCharlie Youlden2 days ago0Comments